Concord Medical Files 2023 Annual Report on Form 20-F
- ByInvesting.com
- •
Concord Medical Services Holdings Limited, an investment holding company, operates a network of radiotherapy and diagnostic imaging centers in the People’s Republic of China. It operates through two segments: Network and Hospital. The company’s services include linear accelerators and external beam radiotherapy, proton therapy system, gamma knife radiosurgery, and diagnostic imaging services. It also offers cyberKnife systems, positron emission tomography-magnetic resonance scanners, and proton therapy systems. In addition, the company provides clinical support services, such as developing treatment protocols for doctors, and organizing joint diagnosis between doctors in its network and clinical research, as well as helps to recruit and determine the compensation of doctors and other medical personnel. Further, the company offers radiotherapy and diagnostic equipment leasing, management services, and premium cancer and proton treatment services to hospitals, as well as teleconsultation and medical information technology services; and sells medical equipment. Additionally, it operates specialty cancer hospitals, which offers radiation, imaging, test laboratory, inpatient, and nursing services. Concord Medical Services Holdings Limited was founded in 1997 and is headquartered in Beijing, the People’s Republic of China.